pasireotide

FDA Drug Profile — Signifor, Signifor LAR

pasireotide is listed in the FDA National Drug Code directory with 13 NDC codes, marketed under brand names including Signifor, Signifor LAR. Available dosage forms: injection, injection, powder, for suspension, kit.

Drug details

Generic Name
pasireotide
Brand Names
Signifor, Signifor LAR
Application Number
NDA200677
Sponsor
Recordati Rare Diseases, Inc.
NDC Codes
13
Dosage Forms
INJECTION, INJECTION, POWDER, FOR SUSPENSION, KIT
Routes
SUBCUTANEOUS
Active Ingredients
PASIREOTIDE

Indications and Usage

1 INDICATIONS AND USAGE SIGNIFOR is a somatostatin analog indicated for the treatment of adult patients with Cushing's disease for whom pituitary surgery is not an option or has not been curative ( 1 ) 1.1 Cushing's Disease SIGNIFOR is indicated for the treatment of adult patients with Cushing's disease for whom pituitary surgery is not an option or has not been curative.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.